GASTROESOPHAGEAL CARCINOMA

Clinical trials for GASTROESOPHAGEAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GASTROESOPHAGEAL CARCINOMA trials appear

Sign up with your email to follow new studies for GASTROESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for hard-to-treat cancers: experimental drug combo targets MTAP-deleted tumors

Disease control Recruiting now

This early-phase study tests the safety of an experimental drug (BMS-986504) when given together with standard cancer treatments. It includes up to 60 adults with advanced mesothelioma, stomach/esophageal cancer, or bladder cancer whose tumors lack the MTAP gene. The main goal is…

Matched conditions: GASTROESOPHAGEAL CARCINOMA

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 29, 2026 15:05 UTC

GASTROESOPHAGEAL CARCINOMA

Get alerted when new GASTROESOPHAGEAL CARCINOMA trials appear

New hope for hard-to-treat cancers: experimental drug combo targets MTAP-deleted tumors